Clinical trial Recruiting at 1 site Interventional Ages 18 to 99

Testing lipoprotein levels in patients with lymphedema

Official title: Testing for Increased Lipoproteins (a) [LP(a)] in Lymphedema Patients: Li-LY

Run by Centre Hospitalier Universitaire de Nice · NCT05962827 · Data updated 2026-11-12

This study is testing if people with lymphedema have higher levels of a certain type of fat in their blood that could increase their risk of heart problems.

Quick facts

Study typeInterventional
Ages18 Years to 99 Years
SexAll
Enrollment100 (estimated)
SponsorCentre Hospitalier Universitaire de Nice
Academic / other
Locations2 sites (Nice, France and 1 other locations)
StatusRecruiting
StartedDecember 8, 2023
Main results expectedJune 8, 2027
Study endsJune 8, 2027
Registry record updatedAugust 31, 2026
Trial IDNCT05962827 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 with confirmed primary or secondary lymphedema.

Probably not a fit

Patients who are pregnant, breastfeeding, or undergoing secondary cardiovascular prevention may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the levels of lipoprotein(a) in patients suffering from lymphedema, a condition characterized by lymph accumulation in tissues. Participants undergoing intensive inpatient decongestive therapy will have their blood tested for various lipid levels, including lipoprotein(a), to assess cardiovascular risk. The research aims to understand the relationship between lymphedema and elevated lipoprotein(a) levels, which are linked to increased cardiovascular risks. The study is conducted at Nice University Hospital, focusing on both primary and secondary lymphedema patients.

Why it matters

Potential benefit: If successful, this study could lead to improved cardiovascular risk management in lymphedema patients.

How similar studies have gone: While the specific approach of testing lipoprotein(a) in lymphedema patients is novel, similar studies have shown the importance of lipid management in cardiovascular risk.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients over 18 years of age.
* Patient with primary or secondary lymphedema confirmed at consultation or in day hospital.
* Signature of informed consent.
* Person affiliated to or benefiting from a social security scheme

Exclusion Criteria:

* Person refusing informed consent.
* Pregnant or breast-feeding women (urine pregnancy test performed in women of -childbearing age).
* Patients undergoing secondary cardiovascular prevention (MI, stroke, AOMI, etc.).
* Persons deprived of their liberty by judicial or administrative decision, persons under legal protection.

Where it's running

  • Chu de Nice
    Nice, France, France
    Recruiting
  • Centre antoine lacassagne
    Nice, France, France
    Terminated

Study contacts

  • Principal investigator: Verena FASSBENDER — Centre Hospitalier Universitaire de Nice
  • Study coordinator: Verena FASSBENDER
  • Email: fassbender.v@chu-nice.fr
  • Phone: 0492034702

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.